NO20002099D0 - 6,11-bro-erytromycinderivater - Google Patents

6,11-bro-erytromycinderivater

Info

Publication number
NO20002099D0
NO20002099D0 NO20002099A NO20002099A NO20002099D0 NO 20002099 D0 NO20002099 D0 NO 20002099D0 NO 20002099 A NO20002099 A NO 20002099A NO 20002099 A NO20002099 A NO 20002099A NO 20002099 D0 NO20002099 D0 NO 20002099D0
Authority
NO
Norway
Prior art keywords
erythromycin derivative
bridged erythromycin
bridged
derivative
erythromycin
Prior art date
Application number
NO20002099A
Other languages
English (en)
Other versions
NO20002099L (no
Inventor
Yat Sun Or
George W Griesgraber
Leping Li
Daniel T Chu
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of NO20002099D0 publication Critical patent/NO20002099D0/no
Publication of NO20002099L publication Critical patent/NO20002099L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00Processes for the preparation of sugar derivatives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
NO20002099A 1997-10-29 2000-04-25 6,11-bro-erytromycinderivater NO20002099L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US96040097A 1997-10-29 1997-10-29
US15826998A 1998-09-22 1998-09-22
PCT/US1998/022941 WO1999021864A1 (en) 1997-10-29 1998-10-29 6,11-bridged erythromycin derivatives

Publications (2)

Publication Number Publication Date
NO20002099D0 true NO20002099D0 (no) 2000-04-25
NO20002099L NO20002099L (no) 2000-06-29

Family

ID=26854886

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20002099A NO20002099L (no) 1997-10-29 2000-04-25 6,11-bro-erytromycinderivater

Country Status (23)

Country Link
EP (1) EP1027361B1 (no)
JP (1) JP2001521038A (no)
KR (1) KR20010031591A (no)
CN (1) CN1278266A (no)
AR (1) AR015986A1 (no)
AT (1) ATE239750T1 (no)
AU (1) AU1286799A (no)
BG (1) BG104425A (no)
BR (1) BR9813317A (no)
CA (1) CA2307828A1 (no)
CO (1) CO4990972A1 (no)
DE (1) DE69814441T2 (no)
DK (1) DK1027361T3 (no)
ES (1) ES2198766T3 (no)
HU (1) HUP0004323A2 (no)
IL (1) IL134996A0 (no)
NO (1) NO20002099L (no)
PL (1) PL340253A1 (no)
PT (1) PT1027361E (no)
SK (1) SK6342000A3 (no)
TR (1) TR200001140T2 (no)
TW (1) TW486485B (no)
WO (1) WO1999021864A1 (no)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6437106B1 (en) 1999-06-24 2002-08-20 Abbott Laboratories Process for preparing 6-o-substituted erythromycin derivatives
US6472372B1 (en) 2000-12-06 2002-10-29 Ortho-Mcneil Pharmaceuticals, Inc. 6-O-Carbamoyl ketolide antibacterials
WO2003024986A1 (en) 2001-09-17 2003-03-27 Ortho-Mcneil Pharmaceutical, Inc. 6-o-carbamate-11,12-lacto-ketolide antimicrobials
NZ533282A (en) 2001-12-05 2006-09-29 Ortho Mcneil Pharm Inc 6-O-Acyl ketolide derivatives of erythromycine useful as antibacterials
US6753318B1 (en) 2002-07-25 2004-06-22 Enanta Pharmaceuticals, Inc. 6,11-4-carbon bridged erythromycin derivatives
US7910558B2 (en) * 2002-05-13 2011-03-22 Enanta Pharmaceuticals, Inc. Bridged macrocyclic compounds and processes for the preparation thereof
KR100661973B1 (ko) 2002-05-13 2006-12-28 이난타 파마슈티칼스, 인코포레이티드 6,11 바이사이클릭 에리스로마이신 유도체
CA2483875C (en) * 2002-05-13 2008-09-23 Enanta Pharmaceuticals, Inc. 6,11 bicyclic erythromycin derivatives
US6841664B2 (en) 2002-07-25 2005-01-11 Enanra Pharmaceuticals, Inc. 6,11-4-carbon bridged ketolides
US7273853B2 (en) 2002-05-13 2007-09-25 Enanta Pharmaceuticals, Inc. 6-11 bicyclic ketolide derivatives
US6645941B1 (en) * 2003-03-26 2003-11-11 Enanta Pharmaceuticals, Inc. 6,11-3C-bicyclic 9a-azalide derivatives
WO2005067564A2 (en) 2004-01-07 2005-07-28 Enanta Pharmaceuticals, Inc. 6-11 bicyclic erythromycin derivatives
WO2005070113A2 (en) 2004-01-09 2005-08-04 Enanta Pharmaceuticals, Inc. 9n-substituted 6-11 bicyclic erythromycin derivatives
WO2005080408A1 (en) * 2004-01-23 2005-09-01 Enanta Pharmaceuticals, Inc. Bridged macrocyclic compounds and processes for the preparation thereof
US7384921B2 (en) 2004-02-20 2008-06-10 Enanta Pharmaceuticals, Inc. Polymorphic forms of 6-11 bicyclic ketolide derivatives
US7384922B2 (en) 2005-05-04 2008-06-10 Enanta Pharmaceuticals, Inc. 6-11 bridged oxime erythromycin derivatives
US7589067B2 (en) 2005-10-12 2009-09-15 Enanta Pharmaceuticals, Inc. 6, 11-bridged tricyclic macrolides
US8273720B2 (en) 2007-09-17 2012-09-25 Enanta Pharmaceuticals, Inc. 6,11-bicyclolides: bridged biaryl macrolide derivatives
US11673910B2 (en) 2017-04-28 2023-06-13 Zikani Therapeutics, Inc. Macrolides with modified desosamine sugars and uses thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR19990067492A (ko) * 1995-11-08 1999-08-25 스티븐 에프. 웨인스톡 트리사이클릭 에리트로마이신 유도체

Also Published As

Publication number Publication date
SK6342000A3 (en) 2000-09-12
BG104425A (bg) 2001-01-31
AR015986A1 (es) 2001-05-30
BR9813317A (pt) 2000-08-22
ES2198766T3 (es) 2004-02-01
PL340253A1 (en) 2001-01-29
CN1278266A (zh) 2000-12-27
DE69814441T2 (de) 2004-04-08
CO4990972A1 (es) 2000-12-26
TW486485B (en) 2002-05-11
TR200001140T2 (tr) 2001-05-21
CA2307828A1 (en) 1999-05-06
IL134996A0 (en) 2001-05-20
DE69814441D1 (de) 2003-06-12
PT1027361E (pt) 2003-09-30
KR20010031591A (ko) 2001-04-16
ATE239750T1 (de) 2003-05-15
EP1027361B1 (en) 2003-05-07
AU1286799A (en) 1999-05-17
DK1027361T3 (da) 2003-08-25
EP1027361A1 (en) 2000-08-16
WO1999021864A1 (en) 1999-05-06
NO20002099L (no) 2000-06-29
HUP0004323A2 (hu) 2001-02-28
JP2001521038A (ja) 2001-11-06

Similar Documents

Publication Publication Date Title
NO2006016I1 (no) 7,8,9,10-tetrahydro-6H-6,10-metanoazepinoÄ4,5-gÜkinoksalintartrat
PT993456E (pt) 4,5-diaril-imidazoles 2-substituidos
ATE435861T1 (de) 12,13-cyclopropan-epothilonderivate
ATE340176T1 (de) Substituierte 6,5-heterobicyclische-derivate
DK0925298T3 (da) Substituerede 6,6-heterobicykliske derivater
ID29241A (id) Turunan-turunan kinolin teranelasi-1,2
DK1000048T3 (da) Substituerede 1,2,3,4-tetrahydronapthalenderivater
ATE275151T1 (de) 3,6-ketal-makrolidantibiotika
DE69718771D1 (de) Substituierte 1,2,3,4-tetrahydronaphthalinderivate
FI952424L (fi) 11,21-bisfenyyli-19-norpregaanijohdannaisia
DE69821009D1 (de) 6,9-verbrückte erythromycin-derivate
NO20002099D0 (no) 6,11-bro-erytromycinderivater
ID21413A (id) Turunan-turunan 1,3,8,-triaza-spiro (4,5) dekan-4-on
NO20003825D0 (no) 1,3,4 - oxadiazolonderivater
LV11898A (lv) Eritromicina atvasinajumi
ATE234839T1 (de) 4,5-azolo-oxindole
EP0766685A4 (en) ARYL, ALKYL, ALKENYL AND ALKINYL MACROLID
DK1068200T3 (da) 2,4,4-trisubstituerede-1,3-dioxolanfungicider
ID24047A (id) Turunan 5-tersubstitusi-3-oksaziazolil 1,6-naftiridin-2 1h-on
ID26368A (id) Turunan-turunan 2 deoksi higromisin
DE69722064D1 (de) 1,25-Dihydroxy-16,22,23-trisdehydro-Cholecalciferol-Derivate
PT984975E (pt) Derivados de eritromicina multiciclicos
BR1100453A (pt) derivados de eritromicina
ZA989848B (en) 6,11-bridged erythromycin derivatives
SI1015467T1 (en) 6,9-bridged erythromycin derivatives

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application